How did CVS's revenue and expenses perform in Q4 2024?


Aime
CVS Health's Q4 2024 financial performance showed a significant decline in revenue and a substantial increase in operating expenses, resulting in a negative net income.
- Revenue Performance:
- CVS Health's revenue for Q4 2024 was -$56.41 billion1.
- This negative revenue indicates a significant decline from the previous quarter's performance, suggesting a challenging financial period for the company.
- Expense Performance:
- The operating expenses for the same quarter were $1.62 billion1.
- Despite the negative revenue, the company's operating expenses remained at a relatively stable level, which could be a cause for concern given the magnitude of the revenue shortfall.
- Net Income:
- The net income for Q4 2024 was -$56.41 billion1.
- The negative net income reflects the company's inability to generate profit during this period, primarily due to the substantial revenue loss compared to the relatively unchanged operating expenses.
In conclusion, CVS Health faced a difficult financial quarter in Q4 2024, characterized by a substantial revenue decline and a negative net income. The company's management will need to address the factors contributing to this revenue shortfall to improve future financial performance.
1/2
CVS Revenue By Business
Date | Business Composition | Revenue By Business |
---|---|---|
20240101-2024 | Intersegment Eliminations | -56.41B |
20240101-2024 | Intersegment Eliminations | -40.55B |
20240101-2024 | Intersegment Eliminations | -26.29B |
20240101-2024 | Intersegment Eliminations | -12.92B |
20240101-2024 | Pharmacy & Consumer Wellness | 28.73B |
20240101-2024 | Corporate | 115.00M |
20240101-2024 | Health Care Benefits | 32.24B |
20240101-2024 | Health Services | 40.29B |
20240101-2024 | Intersegment Eliminations | -12.92B |
Name |
---|
CVS HealthCVS |
CVS HealthCVS |
CVS HealthCVS |
CVS HealthCVS |
CVS HealthCVS |
CVS HealthCVS |
CVS HealthCVS |
CVS HealthCVS |
CVS HealthCVS |
View null result
Source:
1.
CVS Revenue by Business, Net Income, Operating Expenses in Q4 2024
more
less
Continue this conversation 

Explore
Screener
Analysis
Learn
Wiki